BridgeBio Reports Third Quarter 2026 Financial Results and Corporate Updates
- $353.2 million in total third quarter revenues, primarily comprised of $253.2 million of U.S. Attruby net product revenue (up...
Genetic Testing
Nanoscope Therapeutics to Participate in Advanced Therapies USA 2026 in Boston
Co-Founder, CEO Sulagna Bhattacharya to join Keynote Panel on navigating the cell and gene therapy landscape and driving market successCo-Founder,...
Nanoscope Therapeutics to Participate in Advanced Therapies USA 2026 in Boston
Co-Founder, CEO Sulagna Bhattacharya to join Keynote Panel on navigating the cell and gene therapy landscape and driving market successCo-Founder,...
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome, with new preclinical and epidemiological data presented at ASN Kidney Week 2026
PS-003 is designed to address the underlying genetic cause of X-linked Alport Syndrome (XLAS), and new preclinical data demonstrate the restoration...
Baylor Genetics Study Finds Genome Sequencing Identifies Genetic Diagnoses in Nearly One-Third of Children with Intellectual Disability and Developmental Delay
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics, a leading diagnostic genomics partner offering a full spectrum of comprehensive...
Nanoscope Therapeutics Appoints Gene Therapy Operations Leader Troy Short as Senior Vice President, Manufacturing and Supply Chain
Operations and supply chain executive with more than 20 years of experience spanning GMP manufacturing, global clinical and commercial supply, and...
Rhythm Pharmaceuticals Announces Commercial Launch of IMCIVREE® (setmelanotide) in Japan for Patients with Acquired Hypothalamic Obesity
-- Launch follows MHLW approval of IMCIVREE for acquired hypothalamic obesity and inclusion on Japan's National Health Insurance drug price...
Pompe Disease Market Set for Expansion During the Forecast Period (2026-2036) as Growth is Fueled by Next-Generation ERTs, Newborn Screening, and Pipeline Innovation | DelveInsight
The Pompe disease market is estimated to change significantly during the forecast period (2026–2036), owing to the launch of novel...
Encaleret Increased Bone Turnover and Improved Participant-Reported Symptoms in the Phase 3 CALIBRATE Trial in ADH1
- Encaleret administration increased bone turnover, based on its action to recover endogenous PTH secretion in patients with ADH1 -...
Nanoscope Therapeutics to Participate in Eyecelerator 2026 and the American Academy of Ophthalmology 2026 Annual Meeting
Chief Medical Officer Dr. Sam Barone to join the Emerging Innovations in Retinal Therapies panel; Company to present an update...
The Assistance Fund Opens New Program for Glycogen Storage Disorder Type 1A
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Glycogen Storage Disorder Type 1A ORLANDO, FL...
Nanoscope Therapeutics to Present at Meeting on the Mesa 2026
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
Nanoscope Therapeutics to Present at Meeting on the Mesa 2026
Samarendra Mohanty, Co-Founder, President and Chief Scientific Officer, to participate in the premier cell and gene therapy industry conference, October...
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
Proposed Acquisition Valued at Approximately $15 Million Would Add an Established 50-State Telehealth Business, with over 90,000 clients, Focused on...
MyOme and Oracle Collaborate to Advance Genomic Risk Prediction at Global Scale
MyOme's predictive genomic insights that support proactive healthcare run on Oracle Cloud Infrastructure MENLO PARK, Calif., Sept. 24, 2026 /PRNewswire/...
CancerIQ Deepens EHR Integrations to Identify and Guide More Patients Through Cancer Screening, Testing and Surveillance
A redesigned patient experience drives engagement from prevention through survivorship, while chart-aware risk intelligence surfaces guideline-based recommendations in EHR workflowsCHICAGO,...
La Vie Health and Virotek Biosciences Partner to Advance the Next Generation of Precision Health
Ottawa, Ontario and Richmond Hill, Ontario--(Newsfile Corp. - September 15, 2026) - La Vie Health ("La Vie") and Virotek Biosciences...
Nabsys and Indiana University Collaborate to Advance Electronic Genome Mapping Applications in Hematologic Malignancies
Multi-year research collaboration will focus initially on AML and MDS while advancing Electronic Genome Mapping for broader hematologic research applicationsPROVIDENCE,...
Rhythm Pharmaceuticals Announces The New England Journal of Medicine Publication of Phase 3 TRANSCEND Trial Results in Acquired Hypothalamic Obesity
BOSTON, July 08, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming...
Fertility Sensor Market to Reach USD 2.80 Billion by 2033, Driven by At-Home Reproductive Monitoring Surge and Connected Health Integration – Verified Market Research®
The Global Fertility Sensor Market fueled by rising consumer demand for sensor-enabled ovulation tracking and conception planning tools. Wearable fertility...